Working... Menu

A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02285088
Recruitment Status : Completed
First Posted : November 6, 2014
Last Update Posted : February 15, 2018
Information provided by (Responsible Party):
Global Blood Therapeutics